Sign in
4

Changes in Ownership

FENNEC PHARMACEUTICALS INC. Filed Acc 0001926254-26-000018

Chief Executive Officer acquired 2,224 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hackman Jeffrey S. · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-10-12 Grant or award : show line 1 in the form +2,224 $5.53 $12,299 69,685 D
Loading xslF345X06/form4-10132026_041008.xml…